ScreenerHero

BIAFbioAffinity Technologies Inc. Common Stock

NAS · US · Healthcare · Diagnostics & Research · bioaffinitytech.com
0.4000USD-2.20%Mkt Cap: 3.24M $P/E: —

bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United Sta…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$232.67BUSDP/E 33.9
DHR
Danaher Corporation
$153.85BUSDP/E 39.0
LONN
Lonza Group Ltd
$47.21BUSDP/E 38.3
NTRA
Natera, Inc.
$47.86BUSD
A
Agilent Technologies, Inc.
$44.91BUSDP/E 31.9
IDXX
IDEXX Laboratories, Inc.
$43.93BUSDP/E 39.1
IQV
IQVIA Holdings Inc
$42.77BUSDP/E 32.3
WAT
Waters Corporation
$40.32BUSDP/E 103.5
ILMN
Illumina, Inc.
$33.13BUSDP/E 41.0
MTD
Mettler-Toledo International, Inc.
$27.96BUSDP/E 31.5
LH
Labcorp Holdings Inc.
$27.28BUSDP/E 27.8
DGX
Quest Diagnostics Incorporated
$26.97BUSDP/E 26.0
GH
Guardant Health, Inc.
$22.91BUSD
MEDP
Medpace Holdings, Inc.
$17.33BUSDP/E 36.4
ERF
Eurofins Scientific SE
$13.65BUSDP/E 25.3
CRL
Charles River Laboratories International, Inc.
$14.09BUSD
RVTY
Revvity Inc. Common Stock
$13.92BUSDP/E 59.7
ICLR
ICON Public Limited Company
$13.29BUSDP/E 269.1
BIM
bioMerieux S.A.
$9.55BUSDP/E 19.1
TWST
Twist Bioscience Corp.
$9.13BUSD

Key Statistics

Company
Market Cap3.24M $
Enterprise Value2.25M $
Revenue (TTM)5.90M $
Gross Profit1.88M $
Net Income (TTM)-14.91M $
Revenue/Share1.547 USD
Last Price0.4000 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees57
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.67
PEG—
EV/EBITDA-0.19
EV/Revenue0.38
P/S0.55
P/B0.72
EPS (TTM)-0.09
EPS (Forward)-0.60
52W Range
0.32521% of range13.50
52W High13.50 USD
52W Low0.3252 USD
Profitability
Gross Margin30.80%
Oper. Margin-220.77%
EBITDA Margin-202.82%
Profit Margin-244.10%
ROE-204.87%
ROA-136.03%
Growth
Revenue Growth19.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.33M $
CapEx (TTM)60.57K $
FCF Margin-117.09%
FCF Yield-213.20%
Net Debt-994.71K $
Net Debt/EBITDA0.08
Balance Sheet
Debt/Equity0.16
Current Ratio1.44
Quick Ratio1.24
Book Value/Sh0.5560 USD
Cash/Share0.3000 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:30
Split DateSep 19, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.8.10M
Float7.98M
Insiders1.77%
Institutions12.00%
Short Interest
Short Ratio0.8d
Short % Float5.28%
Short % Out.5.21%
Shares Short327.04K
Short (prev mo.)816.64K
Technical
SMA 500.7366 (-45.7%)
SMA 2001.563 (-74.4%)
Beta-1.05
S&P 52W Chg18.16%
Avg Vol (30d)414.85K
Avg Vol (10d)18.08M
Technical Indicators
RSI (14)23.5
MACD-0.1181
MACD Signal-0.1232
MACD Hist.+0.0051
BB Upper0.7348 USD
BB Middle0.5323 USD
BB Lower0.3298 USD
BB Width76.08%
ATR (14)0.0595 USD
Vol Ratio (20d)1.83x